首页> 外文期刊>Physics in medicine and biology. >Dosimetric and microdosimetric study of contrast-enhanced radiotherapy with kilovolt x-rays
【24h】

Dosimetric and microdosimetric study of contrast-enhanced radiotherapy with kilovolt x-rays

机译:千伏X射线对比增强放疗的剂量学和微剂量学研究

获取原文
获取原文并翻译 | 示例
           

摘要

Kilovolt x-rays are clearly suboptimal compared to MV photon beams for radiotherapy of deep-seated tumours because of the increased attenuation in tissue, causing a rapid dose fall-off. This picture could change drastically when tumours can be labelled with contrast medium, containing high atomic number elements. This causes a significant dose enhancement to the tumour by exploiting the high cross sections for the photo-electric effect for kV x-rays. In this work, we have investigated the dosimetric and microdosimetric characteristics of kV contrast-enhanced radiation therapy (CERT) for different photon energies, contrast-medium concentrations and types (I and Gd). Two idealized patient treatment plans (head and lung) for irradiation with CT-arc beams were calculated. It is shown that the dose enhancement in tumours can be highly significant (up to about sixfold for realistic 80-120 kVp x-ray spectra and an iodine concentration of 50 mg ml(-1)) but that dose homogeneity in the tumour depends on photon energy, contrast-medium concentration and type, and irradiation scheme. An attempt to optimize the irradiation scheme is discussed. The microdosimetric study of the dose mean lineal energy shows that radiation quality changes in the contrast-medium-labelled region compared to homogeneous tissue are fairly small and limited to 10%. It is concluded that kV-CERT is a promising radiotherapy technique, provided contrast medium can be delivered reliably to tumours.
机译:与MV光子束相比,对于深部肿瘤的放射治疗,千伏X射线显然次优,这是因为组织衰减增加,导致剂量迅速下降。当可以用含有高原子序数元素的造影剂标记肿瘤时,这种情况可能会发生巨大变化。通过利用高横截面的kV x射线的光电效应,这会显着提高肿瘤的剂量。在这项工作中,我们研究了针对不同光子能量,造影剂浓度和类型(I和Gd)的kV对比增强放射疗法(CERT)的剂量和微剂量特征。计算了两个用CT弧线束照射的理想患者治疗计划(头部和肺部)。结果表明,肿瘤中的剂量增加可能非常显着(对于实际的80-120 kVp X射线光谱和碘浓度为50 mg ml(-1)而言,剂量增加高达大约六倍),但是肿瘤中的剂量均匀性取决于光子能量,造影剂的浓度和类型以及辐照方案。讨论了优化照射方案的尝试。剂量平均线性能量的微剂量研究表明,与均质组织相比,造影剂标记区域的辐射质量变化很小,并且限制在10%以内。结论是,只要能够将造影剂可靠地递送至肿瘤,kV-CERT是一种有前途的放射治疗技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号